US OptionsDetailed Quotes

NMRA240719P17500

Watchlist

7.20
0.000.00%

15min DelayClose Jul 17 15:58 ET

0.00High0.00Low

Neumora Therapeutics Stock Discussion

Moomoo AI

Jan 22 06:02

Ms. Pai Panandiker's appointment, with her vast neuropsychiatry commercial expertise, is seen as invaluable for Neumora's potential commercialization of navacaprant and pipeline advancement. Her experience in neuroscience product commercialization is expected to boost Neumora's growth.

Press Release: Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

Moomoo AI

Dec 12, 2023 06:06

CEO of Neumora Therapeutics is optimistic over Mr. Duncan's appointment due to his legal expertise and program strategy, valuable to the company's goal of advancing neuroscience drug development. Duncan highlights Neumora's leading brain disorder pipeline and recent clinical progress.

Press Release: Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer

Moomoo AI

Oct 10, 2023 06:54

CEO of Neumora, Henry Gosebruch, values Dr. Lenz's successful trial experience and neuroscience expertise for their pipeline development. Dr. Lenz is excited to contribute significantly to Neumora's R&D and neuropsychiatry programs.

Press Release: Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development

Mcsnacks H Tupack

Sep 26, 2023 07:54

Top squeeze stocks

$Axcella Health(AXLA.US)$ Ranked #1 by Fintel. Its next run should take it to about 14.90.
$Ontrak(OTRK.US)$ Has been out of shares for a week. Small float and cheap price. Can run as high as 2.94 when it finally does get volume.
$Neumora Therapeutics(NMRA.US)$ Recent IPO and has been steady moving up from its low of 9.80. Now comes the bigger gap ups . 17.74 is its breakout.
$Prestige Wealth(PWM.US)$ Seems to have found bottom at 3.10. If it has ER on October 6 that is. S...